These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37729770)

  • 41. Periventricular white matter hyperintensity burden and cognitive impairment in early Parkinson's disease.
    Huang X; Wen MC; Ng SY; Hartono S; Chia NS; Choi X; Tay KY; Au WL; Chan LL; Tan EK; Tan LC
    Eur J Neurol; 2020 Jun; 27(6):959-966. PubMed ID: 32124496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterizing the white matter hyperintensity penumbra with cerebral blood flow measures.
    Promjunyakul N; Lahna D; Kaye JA; Dodge HH; Erten-Lyons D; Rooney WD; Silbert LC
    Neuroimage Clin; 2015; 8():224-9. PubMed ID: 26106546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.
    Pozorski V; Oh JM; Okonkwo O; Krislov S; Barzgari A; Theisen F; Sojkova J; Bendlin BB; Johnson SC; Gallagher CL
    Neuroimage Clin; 2019; 23():101870. PubMed ID: 31150958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tract Specific White Matter Lesion Load Affects White Matter Microstructure and Their Relationships With Functional Connectivity and Cognitive Decline.
    Kim T; Aizenstein HJ; Snitz BE; Cheng Y; Chang YF; Roush RE; Huppert TJ; Cohen A; Doman J; Becker JT
    Front Aging Neurosci; 2021; 13():760663. PubMed ID: 35185514
    [TBL] [Abstract][Full Text] [Related]  

  • 45. White Matter Hyperintensities Mediate Impact of Dysautonomia on Cognition in Parkinson's Disease.
    Dadar M; Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB; Collins DL
    Mov Disord Clin Pract; 2020 Aug; 7(6):639-647. PubMed ID: 32775509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns.
    Pålhaugen L; Sudre CH; Tecelao S; Nakling A; Almdahl IS; Kalheim LF; Cardoso MJ; Johnsen SH; Rongve A; Aarsland D; Bjørnerud A; Selnes P; Fladby T
    J Cereb Blood Flow Metab; 2021 May; 41(5):1162-1174. PubMed ID: 32955960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of estimated white matter hyperintensity age with cognition in elderly with controlled hypertension.
    Sung Kim J; Bin Bae J; Won Han J; Jong Oh D; Wan Suh S; Hyoung Kim J; Woong Kim K
    Neuroimage Clin; 2023; 37():103323. PubMed ID: 36638599
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dysfunctional Architecture Underlies White Matter Hyperintensities with and without Cognitive Impairment.
    Zhu W; Huang H; Yang S; Luo X; Zhu W; Xu S; Meng Q; Zuo C; Zhao K; Liu H; Liu Y; Wang W
    J Alzheimers Dis; 2019; 71(2):461-476. PubMed ID: 31403946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. White matter hyperintensities associated with progression of cerebral small vessel disease: a 7-year Chinese urban community study.
    Xia Y; Shen Y; Wang Y; Yang L; Wang Y; Li Y; Liang X; Zhao Q; Wu J; Chu S; Liang Z; Wang X; Qiu B; Ding H; Ding D; Cheng X; Dong Q
    Aging (Albany NY); 2020 May; 12(9):8506-8522. PubMed ID: 32388497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
    Hanning U; Teuber A; Lang E; Trenkwalder C; Mollenhauer B; Minnerup H
    Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pattern of regional white matter hyperintensity volume in mild cognitive impairment subtypes and associations with decline in daily functioning.
    Bangen KJ; Thomas KR; Weigand AJ; Sanchez DL; Delano-Wood L; Edmonds EC; Carmichael OT; Schwarz CG; Brickman AM; Bondi MW;
    Neurobiol Aging; 2020 Feb; 86():134-142. PubMed ID: 31791658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
    Chahine LM; Dos Santos C; Fullard M; Scordia C; Weintraub D; Erus G; Rosenthal L; Davatzikos C; McMillan CT
    Eur J Neurol; 2019 Feb; 26(2):246-e18. PubMed ID: 30169897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patterns of white matter hyperintensities associated with cognition in middle-aged cognitively healthy individuals.
    Brugulat-Serrat A; Salvadó G; Sudre CH; Grau-Rivera O; Suárez-Calvet M; Falcon C; Sánchez-Benavides G; Gramunt N; Fauria K; Cardoso MJ; Barkhof F; Molinuevo JL; Gispert JD;
    Brain Imaging Behav; 2020 Oct; 14(5):2012-2023. PubMed ID: 31278650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Only White Matter Hyperintensities Predicts Post-Stroke Cognitive Performances Among Cerebral Small Vessel Disease Markers: Results from the TABASCO Study.
    Molad J; Kliper E; Korczyn AD; Ben Assayag E; Ben Bashat D; Shenhar-Tsarfaty S; Aizenstein O; Shopin L; Bornstein NM; Auriel E
    J Alzheimers Dis; 2017; 56(4):1293-1299. PubMed ID: 28157096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination of white matter hyperintensities and Aβ burden is related to cognitive composites domain scores in subjective cognitive decline: the FACEHBI cohort.
    Ortega G; Espinosa A; Alegret M; Monté-Rubio GC; Sotolongo-Grau O; Sanabria A; Tartari JP; Rodríguez-Gómez O; Marquié M; Vivas A; Gómez-Chiari M; Alarcón-Martín E; Pérez-Cordón A; Roberto N; Hernández I; Rosende-Roca M; Vargas L; Mauleón A; Abdelnour C; Esteban De Antonio E; López-Cuevas R; Alonso-Lana S; Moreno-Grau S; de Rojas I; Orellana A; Montrreal L; Tárraga L; Ruiz A; Boada M; Valero S;
    Alzheimers Res Ther; 2021 Aug; 13(1):141. PubMed ID: 34404456
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decline in executive function in patients with white matter hyperintensities from the static and dynamic perspectives of amplitude of low-frequency fluctuations.
    Cao S; Zhang J; Chen C; Wang X; Ji Y; Nie J; Tian Y; Qiu B; Wei Q; Wang K
    J Neurosci Res; 2021 Nov; 99(11):2793-2803. PubMed ID: 34510531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cognitive and motor correlates of grey and white matter pathology in Parkinson's disease.
    Dadar M; Gee M; Shuaib A; Duchesne S; Camicioli R
    Neuroimage Clin; 2020; 27():102353. PubMed ID: 32745994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Painting by lesions: White matter hyperintensities disrupt functional networks and global cognition.
    Crockett RA; Hsu CL; Dao E; Tam R; Eng JJ; Handy TC; Liu-Ambrose T
    Neuroimage; 2021 Aug; 236():118089. PubMed ID: 33882347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease.
    Wang T; Jin A; Fu Y; Zhang Z; Li S; Wang D; Wang Y
    Front Immunol; 2021; 12():803504. PubMed ID: 34956241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DEWS (DEep White matter hyperintensity Segmentation framework): A fully automated pipeline for detecting small deep white matter hyperintensities in migraineurs.
    Park BY; Lee MJ; Lee SH; Cha J; Chung CS; Kim ST; Park H
    Neuroimage Clin; 2018; 18():638-647. PubMed ID: 29845012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.